Mounjaro

Mounjaro is administered as a subcutaneous injection, typically once a week. Your healthcare provider will determine the appropriate starting dose, usually 2.5 mg, which can be gradually increased based on your response and tolerance. Always follow the prescribed dosage instructions carefully and avoid exceeding the recommended dose. If you miss a dose, take it as soon as possible, but ensure there is at least 72 hours before your next scheduled injection.

Each injection of Mounjaro contains the active ingredient tirzepatide in pre-measured doses, ranging from 2.5 mg to 15 mg, depending on the prescription. Additional components include sodium chloride, water for injection, and stabilizing agents to ensure the medication’s effectiveness and safety.

The manufacturer of Mounjaro is:

Eli Lilly and Company
Indianapolis, IN 46285
USA

Like any medication, Mounjaro may cause side effects. Common side effects include nausea, vomiting, diarrhoea, and decreased appetite. These symptoms often diminish as your body adjusts to the medication. Serious side effects are rare but may include pancreatitis, severe allergic reactions, or low blood sugar. Contact your doctor immediately if you experience symptoms such as severe abdominal pain, swelling, or difficulty breathing.

Mounjaro is not suitable for everyone. Avoid using this medication if you have a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or are allergic to tirzepatide or any of its ingredients. Inform your healthcare provider if you are pregnant, breastfeeding, or have a history of pancreatitis or severe gastrointestinal issues. Regular monitoring of your blood sugar levels is essential while using Mounjaro.